Drug-induced systemic lupus erythematosus: a critical review.
D000328:Adult; D000493:Allopurinol / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects; D012110:Reserpine / Q000009:adverse effects / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects; D014376:Tuberculosis / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D000927:Anticonvulsants; D013956:Antithyroid Agents; D000995:Antitubercular Agents; D003280:Contraceptives, Oral, Synthetic; D011619:Psychotropic Drugs; D013449:Sulfonamides; D006830:Hydralazine; D000493:Allopurinol; D012110:Reserpine; D010396:Penicillamine; D011342:Procainamide